A chest drainage system securing apparatus for securing and maintaining chest drainage systems in position following placement into a human or animal patient and preventing movement or unplanned removal thereof in response to the application of significant forces in any direction thereto, be they longitudinal, torsional/rotational or bending. The securement system includes retention devices secured to a chest tube which interact with an adhesive pad releasably attached to a patient to ensure proper positioning of the chest tube. The adhesive pad includes one or more Heimlich-type valves for sealing sucking chest wounds and for sealing an incision formed in a patients skin and chest for the placement and insertion of a chest tube.

An indwelling pleural catheter system comprises an indwelling catheter device (2) comprising a catheter tube (7) with a fenestrated distal end (7A) configured to reside in the pleural cavity of a subject and a connection hub (10) fluidically coupled to a proximal end (7B) of the catheter tube, a skin anchoring member (3) to anchor the connection hub (10) to the skin of the subject, and optionally a detachable ambulatory suction module (4) configured for detachable attachment to the connection hub (10). The suction module (4) comprises a fluid inlet (19) configured for fluidic coupling to the catheter tube (7) through the connection hub (10) and a fluid outlet (20) configured for detachable fluidic coupling to a pleural fluid drainage system (5) to drain pleural fluid through the detachable ambulatory suction module. The detachable ambulatory suction module is configured to exert a negative pressure in the catheter tube upon detachment of the pleural fluid drainage system from the suction module. Treatment of pleural effusion using the system of the invention is described. An indwelling catheter system for draining fluid from the peritoneal cavity, and methods of treating ascites, is also described.

A chemo-o-port cover includes flexible and stretchable material sized to cover the skin surface immediately above the implanted port and a centered ring structure secured on its surface to hold numbing cream. The thickness of the cover permits the cover to provide a barrier and movement. The height and diameter of the ring defines a volume sufficient to contain an amount of numbing cream to reduce or eliminate the pain associated with injecting the chemotherapy medicament into the implanted port structure. The stretchable material also contains adhesive regions to secure the cover to the skin of the patient and keep the cover in place for long periods of time. The adhesive permits repeated use of the cover—removal and reapplication.

This invention relates to a catheter cover. Previously, catheter covers that may protect a catheter from water were not efficiently securable to a human user. Embodiments of the present invention use a tab (50) joined to a sleeve on the catheter cover. A first adhesive strip (52) is joined to the tab and the sleeve and is configured to be attached to skin of a human user.

A vascular access device may include a housing, which may include a distal end, a proximal end, and a lumen extending through the distal end of the housing and the proximal end of the housing. The distal end of the housing may include a connector configured to couple to a catheter assembly. The vascular access device may include a bag, which may be coupled to the proximal end of the housing. The vascular access device may include an instrument and a pincher disposed within the bag. The pincher may be configured to pinch the instrument to move the instrument distally through the lumen of the housing and into the catheter assembly.

An interface device for implantation in a subject includes a tissue integration layer and a crowning element. The tissue integration layer has a porous structure adapted for ingress of tissue to anchor the device when implanted. The crowning element is adapted for epidermal attachment when the device is implanted and is configured such that once implanted, part of the crowning element extends through the epidermis and is accessible from outside the subject's body. The porous structure of the tissue integration layer is interconnected for tissue ingress during implantation.

A surgical instrument access port assembly and method of use, the surgical instrument access port a surgical instrument has a needle lumen and a surgical access port. The needle lumen extends in a longitudinal direction and includes a needle tip at a distal end, and a body portion at a proximal end, the body portion having at least one recess or finger. The surgical access port has a cannula defining a hollow cannula shaft, and a tapered hub attached to a proximal end of the cannula. The tapered hub includes at least one inner ring configured to abut against the at least one recess or finger while the surgical instrument is inserted into the cannula of the surgical access port.

A port is adapted to be implanted to a body with its top exposed to the environment. The port has a housing defining a chamber that has an opening at the top of the housing. An aperture having a lumen attached thereto is formed at the lower portion of the chamber. For infusion, an insert that has an internal passageway that connects a fluid inlet at its top surface and a bore at its sidewall is sealingly mated to the chamber. The bore sealingly aligns with the aperture. After infusion, the insert is removed, and a blank insert is fitted to the chamber. A band of tissue ingrowth media encircles the housing to form an aseptic barrier where the outer wall of the housing and the tissue of the body encircling the housing meet.

A cover for a percutaneous connector extending through the skin of a patient. The cover includes a structure having an inner side and an outer side. A first separable connector is mounted to the structure and disposed entirely within the structure, the first separable connector being configured to detachably engage and electrically connect with the percutaneous connector. A second separable connector is mounted to the structure and electrically connected to the first separable connector, the second separable connector being exposed at the outer side of the structure and being configured to detachably engage and electrically connect with an external device. The inner side of the structure defines a skin-engaging surface at least partially surrounding the first separable connector and the percutaneous connector, when the first separable connector is engaged with the percutaneous connector.

A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.